TrialThe oncologist2020

Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical Trial.

Juncheng Xuhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.